One study showed that sST2 and IL-33 were associated with mortality in patients with ST elevation myocardial infarction (STEMI) but not in patients with non-STEMI (NSTEMI) or stable angina pectoris (SAP) [27]. This evidence concerns the gene IL33 and ST Elevation Myocardial Infarction.